Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Sectra has completed the acquisition of Oxipit, a healthcare it business in Sweden. Sectra acquisitions focus on radiology AI, and Oxipit provides autonomous artificial intelligence tools for imaging workflows and clinical decision support. The healthcare M&A adds capabilities for AI-driven analysis in radiology, supporting faster interpretation and improved consistency across healthcare facilities. This add on acquisition is a strategic acquisition by a strategic buyer, with deal size undisclosed, and it expands Sectra’s healthcare technology portfolio through an add on acquisition approach.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026